🇺🇸 FDA
Patent

US 7880007

Bicyclic substituted phenyl piperidine modulators of muscarinic receptors

granted A61KA61K31/4439A61P

Quick answer

US patent 7880007 (Bicyclic substituted phenyl piperidine modulators of muscarinic receptors) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/4439, A61P, A61P1/04, A61P11/06